skip to main content

LAA Occlusion Cannot Replace Mechanical Valve Anticoagulation — EECC MCQ

Instant feedback + full explanation. One question, done properly.

ModerateValvular Heart DiseaseLAA Occlusion Cannot Replace Mechanical Valve AnticoagulationEECC

A 72-year-old man with a mechanical aortic valve develops recurrent GI bleeding that requires repeated blood transfusions. He is on warfarin with a target INR of 2.5-3.5. The source of bleeding has been treated endoscopically but recurs. His cardiologist discusses left atrial appendage occlusion. Is LAA occlusion appropriate for patients with mechanical valves who cannot tolerate anticoagulation?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — No — LAA occlusion does NOT replace the need for anticoagulation in mechanical valve patients; mechanical valves require lifelong warfarin for valve thrombosis prevention (not just stroke prevention), and LAA occlusion addresses only the atrial thromboembolic component

This is a critical conceptual point: anticoagulation for mechanical valves serves TWO purposes: (1) prevention of valve thrombosis (thrombus formation on the prosthetic valve surfaces); (2) prevention of thromboembolism (from the LA/LAA, particularly in AF). LAA occlusion addresses only the second component. Even after LAA occlusion, patients with mechanical valves MUST continue warfarin because the prosthetic valve surfaces are thrombogenic — valve thrombosis can cause acute obstruction, embolic stroke, and death. Therefore, LAA occlusion cannot solve the anticoagulation-bleeding dilemma in mechanical valve patients. Management options include: (1) lowering the INR target (if clinically appropriate); (2) treating the bleeding source definitively; (3) in extreme cases, redo surgery with bioprosthetic valve replacement (eliminating the warfarin requirement).

Reference: ESC/EACTS (2025): VHD Guidelines; ESC (2024): AF Guidelines